12 studies found for:    "Adrenal cancer"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting A Pilot Study of F-18 Paclitaxel (FPAC) PET for Evaluating Drug Delivery of Solid Tumors in Breast, Lung, Renal, and Adrenal Cancers
Conditions: Breast Cancer;   Lung Cancer;   Renal Cancer;   Adrenal Cancer
Intervention: Drug: F-18 Paclitaxel (FPAC)
2 Recruiting Stereotactic Body Radiation Therapy (SBRT) in Metastatic Non-small Cell Lung Cancer
Conditions: Non-Small-Cell Lung Carcinoma;   Liver Cancer;   Adrenal Cancer
Intervention: Radiation: stereotactic body radiation therapy
3 Active, not recruiting A Targeted Phase I/II Trial of ZD6474 (Vandetanib; ZACTIMA) Plus the Proteasome Inhibitor, Bortezomib (Velcade ), in Adults With Solid Tumors With a Focus on Hereditary or Sporadic, Locally Advanced or Metastatic Medullary Thyroid Cancer (MTC)
Conditions: Breast Cancer;   Colon Cancer;   Prostate Cancer;   Lung Cancer;   Adrenal Cancer;   Renal Cancer;   Gastric Cancer;   Ovarian Cancer;   Cervical Cancer;   Thyroid Cancer;   Sarcoma
Interventions: Drug: VELCADE, PS-341 (Bortezomib, NSC #681239);   Drug: ZACTIMA (Vandetanib) (ZD6474)
4 Unknown  Antineoplaston Therapy in Treating Patients With Stage IV Adrenal Gland Cancer
Condition: Adrenocortical Carcinoma
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
5 Completed Phase II Trial of ZD1839 (Iressa) in Patients With Nonresectable Adrenocortical Carcinoma (ACC)
Condition: Nonresectable Adrenocortical Carcinoma
Intervention: Drug: Iressa (ZD1839)
6 Recruiting Study of Adrenal Gland Tumors
Condition: Adrenal Gland Neoplasm
Intervention:
7 Unknown  Evaluation of Side Effects of Mitotane
Condition: Adrenocortical Carcinoma
Intervention:
8 Recruiting Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms
Conditions: Neuroendocrine Neoplasms;   Thyroid Neoplasms;   Parathyroid Neoplasms;   Adrenal Neoplasm;   Neuroblastoma
Intervention:
9 Recruiting PET Imaging With Tc-94m Sestamibi to Assess Resistance to Chemotherapy
Condition: Neoplasms
Interventions: Drug: Tariquidar;   Radiation: Tc-94m Sestamibi;   Procedure: positron emission tomography;   Procedure: radionuclide imaging
10 Unknown  German Adrenocortical Carcinoma Registry
Condition: Adrenocortical Carcinoma
Intervention:
11 Recruiting Evaluation of Molecular Markers in Adrenal Tumors
Condition: Adrenal Gland Neoplasms
Intervention:
12 Unknown  Sunitinib in Refractory Adrenocortical Carcinoma
Condition: Adrenocortical Carcinoma
Intervention: Drug: Sunitinib

Indicates status has not been verified in more than two years